Form 483

PAI Holdings, LLC, dba Pharmaceutical Associates, Inc Form 483, 2009-06-19

FDA issued a Form 483 to PAI Holdings, LLC, dba Pharmaceutical Associates, Inc on 2009-06-19 with 9 public-safe observations.

483· Form 483 issued9 observations

PAI Holdings, LLC, dba Pharmaceutical Associates, Inc · Greenville, United States · Issued June 19, 2009

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Jun 2009
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Miguel A Martinez, Bill Tackett

19 Jun 2009
21 CFR 211.194(a)

Complete test data included in records

Cited by Miguel A Martinez, Bill Tackett

19 Jun 2009
21 CFR 211.194(d)

Laboratory equipment calibration records

Cited by Miguel A Martinez, Bill Tackett

19 Jun 2009
21 CFR 211.67(b)

Written procedures fail to include

Cited by Miguel A Martinez, Bill Tackett

19 Jun 2009
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Miguel A Martinez, Bill Tackett

Inspected site

Inspection team

BTBill Tackett

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere